Sanofi Group Head, Multiple Sclerosis Research Cluster in Framingham, Massachusetts

The Head of the Multiple Sclerosis Research Cluster in the Neuroscience Therapeutic Area will be a scientific innovator, drive scientific excellence and rigor, and develop and advance cutting-edge therapeutics. The Cluster Head will manage research teams supported by multidisciplinary platforms and scientists based in the Boston area. The Cluster Head will identify and validate new targets using a variety of tools, including human genetics, human sample analyses, bioinformatics, clinical data, and preclinical in vitro and in vivo models, implementing new models and technologies. The Cluster Head will work closely with research and development colleagues to ensure the progression of projects from concept to clinical testing, focusing on developing and validating a strong translational rationale. The Cluster Head will maintain a leadership position in the neuroimmunology, neuroinflammation, remyelination, neuroprotection and neurologic disease research communities, connecting Sanofi scientists with collaborators around the globe. The Cluster Head will work closely with the Head of the Neuroscience Therapeutic Area to develop and integrate a research strategy within the broader neuroscience strategy, contribute to portfolio review and prioritization, and will be part of the Neuroscience Leadership Team, together with Cluster Heads in Neurodegeneration Research, CNS Rare Diseases Research, and group leaders in Translational Neuroscience and CNS Barriers Research.

Key Responsibilities:

  • Lead the Multiple Sclerosis Research Cluster, comprised of approximately 20 FTEs responsible for identifying novel targets and pathways to treat the immunologic, neuroinflammatatory, remyelination, repair and neuroprotection aspects of MS.

  • Lead scientists experienced in a range of disciplines, from molecular and cell biology, neuropharmacology, neurochemistry, electrophysiology and behavior, to develop deep mechanistic understanding of MS pathogenesis and confidence in target rationale,

  • Advance the Neuroscience Therapeutic Area strategy by identifying new targets and advancing projects in the current pipeline. Lead internally and externally by publishing cutting edge science and developing and maintaining key collaborations around the globe.

  • Manage collaborative relationships with project leads, key internal and external stakeholders, and with research platform leadership to resource and advance portfolio projects.

  • Recruit, retain and develop world-class scientific talent.


  • PhD or MD/PhD with postdoctoral and/or fellowship training. 5+ years of experience developing and leading research programs. Experience in drug discovery and development preferred.

  • Deep expertise and outstanding record of research and publications in MS and/or other CNS autoimmune diseases.

  • Expertise in one or more of the following areas: discovery research, translational human biology, early clinical development, human biology approaches, biomarker development and validation, and forward and back translation of research and clinical endpoints.

  • Understanding of complex research landscapes globally, ability to identify cutting-edge research and new directions, and connect internal and external colleagues productively.

  • Experience leading multi-disciplinary, matrixed teams.

  • Outstanding oral communication, management and interpersonal skills.

Sanofi US Services, Inc. and its U.S. affiliates are Equal Opportunity and Affirmative Action employers committed to a culturally diverse workforce. All qualified applicants will receive consideration for employment without regard to race; color; creed; religion; national origin; age; ancestry; nationality; marital, domestic partnership or civil union status; sex, gender, gender identity or expression; affectional or sexual orientation; disability; veteran or military status or liability for military status; domestic violence victim status; atypical cellular or blood trait; genetic information (including the refusal to submit to genetic testing) or any other characteristic protected by law.

Sanofi is a global healthcare leader focused on patients' needs, engaged in the research, development, manufacturing and marketing of therapeutic solutions focused on patients’ needs. Sanofi has core strengths in diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets and Sanofi Genzyme.

At Sanofi, our ambition is to be an integrated global healthcare company, focused on patients’ needs. Much more than just a leading pharmaceutical company, Sanofi is committed to transforming scientific innovations into solutions and services that protect health, enhance life, and respond to the needs of the 7 billion people in the world. We trust our ambition to guide and inspire us as we work to create a future with optimal health and wellness for everyone.

Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.

With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.

Sanofi, Empowering Life